These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3472587)

  • 1. Establishment of three permanent human leukaemia cell lines producing immunoreactive calcitonin.
    Koeppler H; Pflueger KH; Knapp W; Havemann K
    Br J Haematol; 1987 Apr; 65(4):405-9. PubMed ID: 3472587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of immunoreactive calcitonin by myeloid leukaemia cells.
    Foa R; Oscier DG; Hillyard CJ; Incarbone E; McIntyre I; Goldman JM
    Br J Haematol; 1982 Feb; 50(2):215-23. PubMed ID: 6949610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of myeloid differentiation antigens on normal and malignant myeloid cells.
    Griffin JD; Ritz J; Nadler LM; Schlossman SF
    J Clin Invest; 1981 Oct; 68(4):932-41. PubMed ID: 6945311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface antigens in acute myeloblastic leukaemia: a study using heterologous antisera.
    Tupchong L; MacLennan IC
    Br J Cancer; 1978 Oct; 38(4):481-95. PubMed ID: 281967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive calcitonin production by a human promyelocytic leukemia cell line HL60.
    Oscier DG; Hillyard CJ; Arnett TR; MacIntyre I; Goldman JM
    Blood; 1983 Jan; 61(1):61-5. PubMed ID: 6571715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of membrane CD45 isoform expression by leukaemic blasts and normal mature myeloid cells.
    Master PS; Richards SJ; Roberts BE; Scott CS
    Int J Hematol; 1992 Jun; 55(3):235-42. PubMed ID: 1386761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of cell surface antigens induced by 12-O-tetradecanoyl-phorbol 13-acetate in two myeloblastic cell lines, a promyelocytic cell line, and a monoblastic cell line: detection with five monoclonal antibodies.
    Sugimoto T; Tatsumi E; Takeda K; Minato K; Sagawa K; Minowada J
    J Natl Cancer Inst; 1984 Apr; 72(4):923-8. PubMed ID: 6368942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactive calcitonin in leukaemia.
    Hillyard CJ; Oscier DG; Foa R; Catovsky D; Goldman JM
    Br Med J; 1979 Dec; 2(6202):1392-3. PubMed ID: 519475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of SSEA-I antigen (3-fucosyl-N-acetyl-lactosamine) on normal and leukaemic human haemopoietic cells: modulation by neuraminidase treatment.
    Tabilio A; Del Canizo MC; Henri A; Guichard J; Mannoni P; Civin CI; Testa U; Rochant H; Vainchenker W; Breton-Gorius J
    Br J Haematol; 1984 Dec; 58(4):697-710. PubMed ID: 6083798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of calcitonin mRNA expression to the differentiation state of HL 60 cells.
    Kiefer P; Bacher M; Pflüger KH
    Leuk Lymphoma; 1994 May; 13(5-6):501-7. PubMed ID: 7520792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell proliferation and protein synthesis in human leukaemic myeloblasts after cytosine arabinoside therapy.
    Wantzin GL; Karle H; Killmann SA
    Br J Haematol; 1976 Feb; 32(2):283-9. PubMed ID: 1061618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased release of microvesicles containing mitochondria is associated with the myeloid differentiation of AML-M5 leukaemia cells.
    Zhao F; Sun L; Yang N; Zheng W; Shen P; Huang Y; Lu Y
    Exp Cell Res; 2020 Oct; 395(2):112213. PubMed ID: 32758487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
    Hu ZB; Ma W; Zaborski M; MacLeod R; Quentmeier H; Drexler HG
    Leukemia; 1996 Jun; 10(6):1025-40. PubMed ID: 8667638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial characterization of a membrane antigen which exhibits specificity for cells of patients with acute myelogenous leukaemia.
    Shipman R; Malcolm A; Levy JG
    Br J Cancer; 1983 Jun; 47(6):849-52. PubMed ID: 6190494
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: New ideas on myeloid leukaemia.
    Lancet; 1974 Mar; 1(7857):546-7. PubMed ID: 4131981
    [No Abstract]   [Full Text] [Related]  

  • 16. Serological detection of B-cell ("Ia-like") antigens in serum of normal donor and in some sera of leukaemic patients.
    Koubek K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):408-15. PubMed ID: 6182060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation linked expression of a myeloid cell surface antigen.
    Roberts MM; Greaves MF
    Br J Haematol; 1978 Apr; 38(4):439-52. PubMed ID: 348227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Report of the Workshop held in Leuven, Belgium, September 15-17, 1986. Second MIC Cooperative Study Group.
    Cancer Genet Cytogenet; 1988 Jan; 30(1):1-15. PubMed ID: 3422036
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute promyelocytic leukaemia: further evidence of the differentiation-linked expression of Ia-like (p28,33) antigens on leukaemic cells.
    McVerry BA; Goldstone AH; Janossy G
    Scand J Haematol; 1979 Jan; 22(1):53-6. PubMed ID: 85330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.